Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4001–4050 of 35128
On March 13, 2025, J. Phillip Holloman, a member of the Board of Directors (the “Board”) of PulteGroup, Inc. (the “Company”), informed the Board of his decision to not stand for re-election at the end of his current term at the Company’s 2025 annual meeting of shareholders scheduled to be held on April 30, 2025
On March 13, 2025, the Board appointed Mr. Patrick McCauley to replace Mr. Papastavrou as Class 3 Director of the Company, to serve until the Company’s annual meeting of stockholder to be held in 2027, or until his successor is duly elected and qualified.
On March 13, 2025, each of Mr. Frederick Herbst and Mr. Jason Papastavrou resigned from his position as Director of the Company.
On March 13, 2025, the Board appointed Mr. Patrick McCauley to replace Mr. Papastavrou as Class 3 Director of the Company.
On March 13, 2025, each of Mr. Frederick Herbst and Mr. Jason Papastavrou resigned from his position as Director of the Company.
On March 13, 2025, the board of directors of the Company (the “Board”) appointed Ms. Supurna VedBrat to replace Mr. Herbst as a Class 1 Director of the Company, to serve until the Company’s annual meeting of stockholders to be held in 2025, or until her successor is duly elected and qualified.
On March 13, 2025, the board of directors of the Company (the “Board”) appointed Ms. Supurna VedBrat to replace Mr. Herbst as a Class 1 Director of the Company
E. Forrest Jones, Jr. resigned from the Board of Directors (the “Board”) and from his positions on all committees of the Board effective March 14, 2025.
the Board approved the appointment of the Company’s current General Counsel and Secretary, Evan H. Jenkins, age 64, to serve as a member of the Board filling the vacancy left by Mr. Jones’ resignation. The Board also approved the appointment of Mr. Jenkins as Vice-Chairman of the Board.
the Board appointed as a director of the Company General John M. “Jack” Keane (Ret.), effective immediately
The Board of Directors (the “Board”) of ACM Research, Inc. (the “Company”) has appointed Charles Pappis to serve as a member of the Board and its Audit Committee, effective March 15, 2025.
appointed (i) Mr. Krishna Shivram to the Board as a Class I director and (ii) Mr. Vasudevan (Vasu) Guruswamy to the Board as a Class III director, both effective March 17, 2025.
appointed (i) Mr. Krishna Shivram to the Board as a Class I director and (ii) Mr. Vasudevan (Vasu) Guruswamy to the Board as a Class III director, both effective March 17, 2025.
On March 12, 2025, Eric K. Brandt advised the Board of Directors (the “Board”) of The Macerich Company (the “Company”) that he will not stand for re-election as a director of the Company at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On March 12, 2025, Jaynie Studenmund, a member of the Board of Directors (the “Board”) of ExlService Holdings, Inc. (the “Company”), notified the Board that she has decided not to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”), at which time she will resign from the Board and the committees on which she currently serves.
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
the Board was reconstituted as follows: (i) David Hallal and Morana Jovan-Embiricos, Ph.D. (designated by AlloVir), (ii) Andrew Oxtoby, Anthony Adamis, Srinivas Akkaraju, M.D., Ph.D., Michael Dybbs, Ph.D., Napoleone Ferrara, M.D., and Samir Patel, M.D.
the Board was reconstituted as follows: (i) David Hallal and Morana Jovan-Embiricos, Ph.D. (designated by AlloVir), (ii) Andrew Oxtoby, Anthony Adamis, Srinivas Akkaraju, M.D., Ph.D., Michael Dybbs, Ph.D., Napoleone Ferrara, M.D., and Samir Patel, M.D.
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
the Board was reconstituted as follows: (i) David Hallal and Morana Jovan-Embiricos, Ph.D. (designated by AlloVir), (ii) Andrew Oxtoby, Anthony Adamis, Srinivas Akkaraju, M.D., Ph.D., Michael Dybbs, Ph.D., Napoleone Ferrara, M.D., and Samir Patel, M.D.
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
the Board was reconstituted as follows: (i) David Hallal and Morana Jovan-Embiricos, Ph.D. (designated by AlloVir), (ii) Andrew Oxtoby, Anthony Adamis, Srinivas Akkaraju, M.D., Ph.D., Michael Dybbs, Ph.D., Napoleone Ferrara, M.D., and Samir Patel, M.D.
the Board was reconstituted as follows: (i) David Hallal and Morana Jovan-Embiricos, Ph.D. (designated by AlloVir), (ii) Andrew Oxtoby, Anthony Adamis, Srinivas Akkaraju, M.D., Ph.D., Michael Dybbs, Ph.D., Napoleone Ferrara, M.D., and Samir Patel, M.D.
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
the Board was reconstituted as follows: (i) David Hallal and Morana Jovan-Embiricos, Ph.D. (designated by AlloVir), (ii) Andrew Oxtoby, Anthony Adamis, Srinivas Akkaraju, M.D., Ph.D., Michael Dybbs, Ph.D., Napoleone Ferrara, M.D., and Samir Patel, M.D.
the Board was reconstituted as follows: (i) David Hallal and Morana Jovan-Embiricos, Ph.D. (designated by AlloVir), (ii) Andrew Oxtoby, Anthony Adamis, Srinivas Akkaraju, M.D., Ph.D., Michael Dybbs, Ph.D., Napoleone Ferrara, M.D., and Samir Patel, M.D.
the Board was reconstituted as follows: (i) David Hallal and Morana Jovan-Embiricos, Ph.D. (designated by AlloVir), (ii) Andrew Oxtoby, Anthony Adamis, Srinivas Akkaraju, M.D., Ph.D., Michael Dybbs, Ph.D., Napoleone Ferrara, M.D., and Samir Patel, M.D.
appointed Mr. Bruce Felt to the Board, effective upon, and to fill the vacancy created by, the resignation of Mr. P. Gregory Garrison from the Board on March 19, 2025
appointed Mr. Sacks to the Board, effective March 19, 2025
the resignation of Mr. P. Gregory Garrison from the Board on March 19, 2025
On March 17, 2025, Michael D. Kandris, a member of the Board, notified the Company that he will not stand for re-election to the Board at the Company’s upcoming 2025 Annual Meeting, and therefore his term as a director will end at the 2025 Annual Meeting.
On March 14, 2025, the Board of Directors (the “Board”) of PROS Holdings, Inc. (the “Company”) appointed Katie May to the Board as an independent director of the Company effective March 18, 2025, to serve as a Class I director with an initial term expiring at the 2026 annual meeting of stockholders.
On March 14, 2025, we appointed Anthony Chapman to our Board of Directors for a three (3) year term.
On March 17, 2025, the Board of Directors (the “Board”) of RumbleOn, Inc. (the “Company”) appointed Rachel Richards as a director of the Company to fill the vacant seat created by Michael Kennedy’s resignation on January 13, 2025.
The Board appointed Ms. Sun as a Class III Director of the Board, with her initial term to extend until the 2027 Annual Meeting of Stockholders, and appointed her as the Chair of the Audit Committee of the Board and as a member of the Compensation Committee of the Board.
The Board appointed Dr. Bumpus as a Class III Director of the Board, with her initial term to extend until the 2027 Annual Meeting of Stockholders, and appointed her as a member of the Nominating Committee of the Board, the Research and Development Committee of the Board, and the Technology Committee of the Board.
On March 12, 2025, Eric Leupold notified Forge Global Holdings, Inc. (the “Company”) of his intention to resign from the Company’s Board of Directors (the “Board”), effective March 17, 2025.
On March 17, 2025, based upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Brian McDonald as a Class III director, with his initial term expiring at the Company’s 2025 annual meeting of stockholders.
appointed Douglas Williams, PhD as a Class I director
On March 18, 2025, director E. Warren Matthews notified the Board of Directors of Carter Bankshares, Inc. (the “Company”) that he will retire and not stand for re-election to the Board of Directors of the Company (the “Board”) at its 2025 Annual Meeting of Shareholders to be held on May 28, 2025 (the “Annual Meeting”).
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
appointed the following new directors to the Board of Directors of Fannie Mae: • Clinton Jones • William J. Pulte • Christopher Stanley • Michael Stucky
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.